Prominent Florida eye doctor acquitted of Medicare fraud in billing for cancer treatments [Miami Herald]
A prominent
Dr.
“The jurors came out of the courthouse, shook our hands and said, ‘You made it very easy for us,’ “ Rosecan’s defense attorney,
At trial, federal prosecutors tried to prove that Rosecan falsely diagnosed eight patients with choroidal melanoma, a tumor of the eye originating in the choroid, which is a vascular layer of tissue located behind the retina. Prosecutor
In total, according to an indictment, Rosecan was accused of falsely billing about
But the
Rosecan, who received a B.A. degree in molecular biophysics and biochemistry from
Rubio, who worked on Rosecan’s defense with attorney
The case against Rosecan was filed during the depths of the pandemic, with the clock ticking on the statute of limitations.
In March of 2021, Ruiz denied Rosecan’s dismissal motion and sided with the prosecutors, citing the specific language of the federal statute of limitations. To wit: “Except as otherwise expressly provided by law, no person shall be prosecuted, tried, or punished for any offense, not capital, unless the indictment is found or the information is instituted within five years next after such offense shall have been committed.”
In other words, Ruiz concluded that the prosecutors acted lawfully because they “instituted,” or began, the process of prosecuting the physician by information, saying it is allowable under the statute of limitations dating back to the 1790 Crimes Act.
In the end, the judge’s initial ruling didn’t matter. The prosecutors eventually obtained a grand jury indictment in 2021 and lost their case against Rosecan this week.
©2022 Miami Herald. Visit miamiherald.com. Distributed by Tribune Content Agency, LLC.


The American Bar Association (ABA) – Discussion
Prominent Florida eye doctor acquitted of Medicare fraud in billing for cancer treatments [Miami Herald]
Advisor News
- Flourish brings private-bank-like cash solution to MassMutual’s network
- Majority of Americans concerned recent market highs are unsustainable
- GLP-1 users choose between medication and retirement saving
- Gen X and millennials seek new retirement model
- Are families ready for the costs of aging at home?
More Advisor NewsAnnuity News
- New class-action lawsuit targets Delaware Life over annuity disclosures
- A client remarried: Does their annuity still fit?
- Gen X and millennials seek new retirement model
- Global Atlantic names Dan Farrelly head of IMO and IBD channels
- A rising retirement challenge: The license to spend
More Annuity NewsHealth/Employee Benefits News
Life Insurance News